Clinical trials
Phase 1 Anemia trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
93 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2004 | 2 |
| 2005 | 2 |
| 2006 | 6 |
| 2007 | 3 |
| 2008 | 4 |
| 2009 | 3 |
| 2010 | 3 |
| 2011 | 11 |
| 2012 | 6 |
| 2013 | 5 |
| 2014 | 8 |
| 2015 | 7 |
| 2016 | 3 |
| 2017 | 7 |
| 2018 | 1 |
| 2019 | 3 |
| 2020 | 3 |
| 2022 | 1 |
| 2023 | 4 |
| 2024 | 2 |
| 2025 | 5 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 70 |
| Recruiting | 8 |
| Terminated | 8 |
| Withdrawn | 5 |
| Unknown status | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| GlaxoSmithKline | 14 |
| Akebia Therapeutics | 4 |
| Bayer | 3 |
| Apellis Pharmaceuticals, Inc. | 2 |
| Chong Kun Dang Pharmaceutical | 2 |
| Eli Lilly and Company | 2 |
| Medical Research Council | 2 |
| National Cancer Institute (NCI) | 2 |
| National Heart, Lung, and Blood Institute (NHLBI) | 2 |
| Pharmacosmos A/S | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Anemia | 93 |
| Renal Insufficiency, Chronic | 14 |
| Anemia, Iron-Deficiency | 7 |
| Hematologic Diseases | 7 |
| Myelodysplastic Syndromes | 7 |
| Iron Deficiencies | 5 |
| Thrombocytopenia | 5 |
| Kidney Failure, Chronic | 4 |
| Renal Insufficiency | 4 |
| Anemia, Hemolytic | 3 |
Trials
Showing 1 to 25 of 93. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.